Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18–21 mutations

Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18–21 mutations

Introduction: EGFR targeted therapies, have been proved beneficial for patients with HCC, nevertheless additional research on EGFR immunoexpresion and EGFR mutations is still needed, especially in population in which it has not been done yet. The aim of this study is to evaluate EGFR immunoexpressio...

Full description

Bibliographic Details
Main Authors: Nikolova Dafina, Trajkovska Meri, Trpcevska Emilija Nikolovska, Eftimov Aleksandar, Jovanovik Rubens, Janevska Vesna
Format: Article
Language:English
Published: Sciendo 2022-09-01
Series:Romanian Journal of Internal Medicine
Subjects:
epidermal growth factor receptor
hepatocellular carcinoma
survival
gene mutation
exon 18–21
immunohistochemistry
hepatitis b virus infection
Online Access:https://doi.org/10.2478/rjim-2022-0006

Internet

https://doi.org/10.2478/rjim-2022-0006

Similar Items